The Problem:
It touches each one of us at some point in our lives
Heart disease is the leading cause of death for both men and women in the U.S. and worldwide. Each year, more than 600,000 Americans die of heart disease representing nearly a quarter of all deaths. The number of Americans diagnosed with heart disease is currently 26.6 million, more than 11% of the population.
Heart disease, also commonly referred to as cardiovascular disease, is an umbrella term that refers to any disorder that affects the heart and blood vessels. While heart disease develops slowly in most, some are born with it. The most common type is coronary artery disease, a narrowing of the arteries that accounts for more than half of all heart disease related deaths, and can cause a heart attack. Other heart conditions may affect the valves or the heart’s ability to pump adequately.
Approximately every 34 seconds, an American will have a coronary event, and approximately every 1 minute, 23 seconds, an American will die of one.
A central force in the progress against cardiovascular disease, CRF is a time-tested and proven partner for cardiovascular researchers and educators throughout the world. Since 2000, there has been a 31% decline in morbidity from cardiovascular disease because of cardiovascular interventions.
This extraordinary progress has been driven by the discovery of new medicines and technologies that treat heart disease. But we need to do more. Cardiovascular disease still remains the single greatest cause of death in the U.S. and world-wide, affecting every major population group, no matter gender, race, or ethnicity.
For over 25 years, CRF has helped pioneer innovations and educated doctors on the latest treatments for heart disease. But so much more can be done to help the millions of people worldwide who continue to suffer from the disease. At CRF, we are committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Our Model:
Once you have heart disease, you have it for life. But a vast consortium of scientific thinking is on your side. The Cardiovascular Research Foundation (CRF) is dedicated to identifying, developing and promoting the latest advancements in the treatment of heart disease. Breakthroughs which are resulting in more people surviving, leading active lives, and moving beyond the fear.
Our Mission:
To help doctors improve survival and quality of life for people suffering from heart and vascular disease.
We work to identify, develop and promote the latest advancements in the treatment of heart and vascular disease. By covering all aspects of the research continuum, we’re able to accelerate the speed with which breakthrough therapies reach patients through doctors, improving survival rates and quality of life, faster.
Source: Event Website
Source : Event Website
Event Name | City | State | Atendance | Exhibitors | Date |
---|---|---|---|---|---|
Structural Heart Summit 2021 (TVT + LAA/PFO) | Chicago | Illinois | - | - | Jun 09, 2021 |
Structural Heart Summit 2020 (TVT + LAA/PFO) | Chicago | Illinois | ![]() estimated |
- | Jun 17, 2020 |
Structural Heart Summit 2019 (TVT + LAA/PFO) | Chicago | Illinois | - | - | Jun 12, 2019 |
Event Name | City | State | Atendance | Exhibitors | Date |
---|---|---|---|---|---|
ASE Echo Hawaii 2021 - American Society of Echocardiography | Waimea | Hawaii | ![]() verified |
- | Jan 18, 2021 |
2021 Mayo Clinic Hawaii Echo with Multimodality Imaging - Cardiovascular Medicine CME | Wailea | Hawaii | - | - | Jan 24, 2021 |
Mayo Clinic Arrhythmias and the Heart: A Cardiovascular Update 2020 | Hawaii | ![]() estimated |
- | Feb 01, 2021 | |
Tremblant Interventional Cardiology Meeting - TIC 2021 | Montreal | Quebec | - | - | Feb 03, 2021 |
Valve Disease, Structural Interventions, and Diastology Summit 2021 | - | - | Feb 05, 2021 |